Innovative blood test boosts accuracy of lung cancer screening
In a recent study published in Cancer Discovery, researchers developed and validated a blood-based, cell-free deoxyribonucleic acid (cfDNA) fragmentome assay for lung cancer detection, which, if the results were positive, would be followed by low-dose computed tomography (LDCT). Introduction Lung cancer is a major death cause, and yearly screening is crucial. However, chest LDCT has [...]